Related Experiment Video
Updated: Aug 17, 2026

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
Published on: November 18, 2022
[Use of a 3-oxypiridine antioxidant in combined therapy of patients with partial epilepsy]
Abstract:
Fifty-four patients with partial epilepsy (age 18-50 years, 26 males and 28 females, illness duration from 6 months to 18 years) have been examined. Idiopathic epilepsy was diagnosed in 7 patients, symptomatic in 36, cryptogenic in 11. The control group comprised 22 sex- and age-matched individuals. All the patients underwent computerized EEG and pharmaco-EEG testing, MRI or CT of the brain. Follow-up duration was from 6 months to 2.5 years. An antioxidant therapeutic course was conducted during 30 days on the background of the basic anticonvulsive therapy with carbamazepine (finlepsin-retard 200) received in individual dosages. Computer EEG analysis was made using "BRAINWIN" soft (Mitrofanov A.A., "Statokin", Moscow). To estimate the effect of the medications on bioelectric brain activity, methods of spectral and coherent EEG analysis, localization of equivalent dipole source of paroxysmal activity were applied. After a 30-day course of combined therapy with carbamazepine (finlepsin-retard 200) and antioxidant Mexicor, inhibition of generator activity of limbic and hypothalamic as well as stem and cerebellum structures and displacement of generator zones into cortical hemisphere structures were observed that may be explained by enhancement of determinant foci of the cortical structures in inhibition of secondary foci. It may be considered as a favorable prognostic factor, which reduces probability of the secondary generalization of partial epileptic seizures.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pharmaceutical Poisoning: Treatment Strategies
